New decision aid aims to boost liver cancer detection in veterans
NCT ID NCT06061328
First seen Jan 05, 2026 · Last updated Jun 12, 2026 · Updated 24 times
Summary
This study tests a new decision aid tool that helps VA medical centers choose the best strategies to improve liver cancer screening for patients with cirrhosis. About 8,020 veterans and VA staff will take part. The goal is to see if the tool helps more patients get the right screening at the right time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240, United States
Conditions
Explore the condition pages connected to this study.